Caffeine use: is there a net benefit for mood and psychomotor performance? 1995

P J Rogers, and N J Richardson, and C Dernoncourt
Consumer Sciences Department, Institute of Food Research, Reading, UK.

We agree with the conclusions of a recent article in this journal [James, Neuropsychobiology 1994;30:124-125] that studies on the psychoactive effects of caffeine need to take into account the possibility that the results obtained might represent merely the reversal of deleterious effects of caffeine deprivation rather than an actual net benefit due to caffeine use. However, in a review of recent studies we find no unequivocal evidence of impaired psychomotor performance associated with caffeine withdrawal. This is in contrast to a clear deterioration of mood which occurs even after overnight caffeine deprivation. We concluded that current evidence points to true performance-enhancing effects of caffeine, although the extent of these and the conditions under which caffeine is most effective have yet to be fully determined. At the same time, the existence of significant detrimental effects of caffeine deprivation on psychomotor performance has not been ruled out.

UI MeSH Term Description Entries
D011597 Psychomotor Performance The coordination of a sensory or ideational (cognitive) process and a motor activity. Perceptual Motor Performance,Sensory Motor Performance,Visual Motor Coordination,Coordination, Visual Motor,Coordinations, Visual Motor,Motor Coordination, Visual,Motor Coordinations, Visual,Motor Performance, Perceptual,Motor Performance, Sensory,Motor Performances, Perceptual,Motor Performances, Sensory,Perceptual Motor Performances,Performance, Perceptual Motor,Performance, Psychomotor,Performance, Sensory Motor,Performances, Perceptual Motor,Performances, Psychomotor,Performances, Sensory Motor,Psychomotor Performances,Sensory Motor Performances,Visual Motor Coordinations
D002110 Caffeine A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. 1,3,7-Trimethylxanthine,Caffedrine,Coffeinum N,Coffeinum Purrum,Dexitac,Durvitan,No Doz,Percoffedrinol N,Percutaféine,Quick-Pep,Vivarin,Quick Pep,QuickPep
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000339 Affect The feeling-tone accompaniment of an idea or mental representation. It is the most direct psychic derivative of instinct and the psychic representative of the various bodily changes by means of which instincts manifest themselves. Mood,Affects,Moods
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance

Related Publications

P J Rogers, and N J Richardson, and C Dernoncourt
August 2009, Current psychiatry reports,
P J Rogers, and N J Richardson, and C Dernoncourt
April 1998, Pharmacology, biochemistry, and behavior,
P J Rogers, and N J Richardson, and C Dernoncourt
January 1985, Psychopharmacology,
P J Rogers, and N J Richardson, and C Dernoncourt
February 2008, Experimental and clinical psychopharmacology,
P J Rogers, and N J Richardson, and C Dernoncourt
April 2003, Psychopharmacology,
P J Rogers, and N J Richardson, and C Dernoncourt
October 2011, Physiology & behavior,
P J Rogers, and N J Richardson, and C Dernoncourt
January 1995, Neuropsychobiology,
P J Rogers, and N J Richardson, and C Dernoncourt
April 2018, Circulation,
P J Rogers, and N J Richardson, and C Dernoncourt
April 2005, Psychopharmacology,
P J Rogers, and N J Richardson, and C Dernoncourt
January 1995, Neuropsychobiology,
Copied contents to your clipboard!